Rezolute Inc (RZLT): A Technical Analysis

RZLT has 36-month beta value of 1.19. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for RZLT is 46.13M, and currently, short sellers hold a 2.73% ratio of that float. The average trading volume of RZLT on September 20, 2024 was 314.38K shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

RZLT) stock’s latest price update

Rezolute Inc (NASDAQ: RZLT)’s stock price has soared by 2.70 in relation to previous closing price of 4.82. Nevertheless, the company has seen a loss of -5.71% in its stock price over the last five trading days. globenewswire.com reported 2024-09-19 that FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S.

RZLT’s Market Performance

Rezolute Inc (RZLT) has experienced a -5.71% fall in stock performance for the past week, with a 13.79% rise in the past month, and a 25.32% rise in the past quarter. The volatility ratio for the week is 5.97%, and the volatility levels for the past 30 days are at 6.24% for RZLT. The simple moving average for the last 20 days is 2.81% for RZLT’s stock, with a simple moving average of 70.73% for the last 200 days.

Analysts’ Opinion of RZLT

Many brokerage firms have already submitted their reports for RZLT stocks, with Guggenheim repeating the rating for RZLT by listing it as a “Buy.” The predicted price for RZLT in the upcoming period, according to Guggenheim is $11 based on the research report published on August 27, 2024 of the current year 2024.

BTIG Research, on the other hand, stated in their research note that they expect to see RZLT reach a price target of $13. The rating they have provided for RZLT stocks is “Buy” according to the report published on July 17th, 2024.

Craig Hallum gave a rating of “Buy” to RZLT, setting the target price at $14 in the report published on June 04th of the current year.

RZLT Trading at 7.55% from the 50-Day Moving Average

After a stumble in the market that brought RZLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.85% of loss for the given period.

Volatility was left at 6.24%, however, over the last 30 days, the volatility rate increased by 5.97%, as shares surge +17.88% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.06% upper at present.

During the last 5 trading sessions, RZLT fell by -4.57%, which changed the moving average for the period of 200-days by +522.28% in comparison to the 20-day moving average, which settled at $4.85. In addition, Rezolute Inc saw 398.74% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RZLT starting from Hogenhuis Wladimir, who purchase 4,815 shares at the price of $4.15 back on Jun 25 ’24. After this action, Hogenhuis Wladimir now owns 37,508 shares of Rezolute Inc, valued at $19,982 using the latest closing price.

ROBERTS BRIAN KENNETH, the Chief Medical Officer of Rezolute Inc, purchase 4,300 shares at $3.91 during a trade that took place back on Jun 14 ’24, which means that ROBERTS BRIAN KENNETH is holding 54,352 shares at $16,828 based on the most recent closing price.

Stock Fundamentals for RZLT

The total capital return value is set at -0.76. Equity return is now at value -57.73, with -53.39 for asset returns.

Based on Rezolute Inc (RZLT), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -21.17. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -22.86.

The liquidity ratio also appears to be rather interesting for investors as it stands at 13.39.

Conclusion

To put it simply, Rezolute Inc (RZLT) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts